Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002618 · ClinicalTrials.gov registry record · Phase 3
Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
A Phase 3 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 242
- Enrollment target
NCT00002618 is a Phase 3 study that has completed, run by Children's Oncology Group. The registered enrollment target is 242 participants.
The verdict
NCT00002618, a Phase 3 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 242 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Giving the drugs in different doses may kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy with various combinations of drugs in treating pediatric patients with advanced-stage large cell lymphoma.
Interventions
- DRUG mercaptopurine
- DRUG leucovorin calcium
- BIOLOGICAL filgrastim
- DRUG doxorubicin hydrochloride
- DRUG cytarabine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 1994-12 |
| Est. Completion | 2006-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002618
The ClinicalTrials.gov registry entry for NCT00002618 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which mercaptopurine is the first listed.
NCT00002618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002618 about?
NCT00002618 is a clinical study titled "Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma". RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Giving the drugs in different doses may kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy with various combinations of drug...
What is the current status of trial NCT00002618?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 242 participants. The study started on 1994-12. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00002618?
The interventions under investigation include: mercaptopurine (DRUG), leucovorin calcium (DRUG), filgrastim (BIOLOGICAL), doxorubicin hydrochloride (DRUG), cytarabine (DRUG).
Who is sponsoring clinical trial NCT00002618?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.